Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase
Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase
About this item
Full title
Author / Creator
Publisher
United States: College of American Pathologists
Journal title
Language
English
Formats
Publication information
Publisher
United States: College of American Pathologists
Subjects
More information
Scope and Contents
Contents
Neurotrophic receptor tyrosine kinase (NTRK) fusion testing has both diagnostic and therapeutic implications for patient care. With 2 tumor-agnostic US Food and Drug Administration-approved tropomyosin receptor kinase (TRK) inhibitors, testing is increasingly used for therapeutic decision making. However, the testing landscape for NTRK fusions is c...
Alternative Titles
Full title
Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2754047658
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754047658
Other Identifiers
ISSN
0003-9985,1543-2165
E-ISSN
1543-2165
DOI
10.5858/arpa.2022-0042-CP
